REFERENCES
  1. Mercuri E, Finkel RS, Muntoni F, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103-115.
  2. Finkel RS, Mercuri E, Meyer OH, et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28(3):197-207.
  3. Chacko A, Sly PD, Gauld L. Polysomnography findings in pediatric spinal muscular atrophy types 1-3. Sleep Med. 2020;68: 124-130.
  4. Mannaa MM, Kalra M, Wong B, et al. Survival probabilities of patients with childhood spinal muscle atrophy. J Clin Neuromuscul Dis. 2009;10(3): 85-89.
  5. Allergy group of Chinese association of pediatricians, Respiration group of Chinese medical association of pediatrics, Rheumatology and immunology group of Chinese association of pediatricians, et al. Clinical diagnosis and treatment path of recurrent respiratory tract infection in children (2022 edition). Chinese Journal of Practical Pediatrics. 2022;37(3):161-168.
  6. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25-e76.
  7. Berry RB, Brooks R, Gamaldo CE, et al. The AASM Manual for Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.3. Darien, Illinois: American Academy of Sleep Medicine, 2016.
  8. World Health Organization. WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: WHO Press. 2006.
  9. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 11(246).2002.
  10. Aguerre V, De Castro F, Mozzoni J, et al. Natural History of Type 1 Spinal Muscular Atrophy in a Series of Argentinian Children. J Neuromuscul Dis. 2020;7(4):453-458.
  11. Pane M, Palermo C, Messina S, et al. An observational study of functional abilities in infants, children, and adults with type 1 SMA. Neurology. 2018;91(8):e696-e703.
  12. Mercuri E, Lucibello S, Pera MC, et al. Long-term progression in type II spinal muscular atrophy: A retrospective observational study. Neurology. 2019;93(13):e1241-e1247.
  13. Qu YJ, Ge XS, Bai JL, et al. Association of copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein gene with the natural history in a Chinese spinal muscular atrophy cohort. J Child Neurol. 2015;30(4):429-436.
  14. Moore GE, Lindenmayer AW, McConchie GA, et al. Describing nutrition in spinal muscular atrophy: A systematic review. Neuromuscul Disord. 2016;26(7):395-404.
  15. McGrattan KE, Graham RJ, DiDonato CJ, et al. Dysphagia phenotypes in spinal muscular atrophy: The past, present, and promise for the future. Am J Speech Lang Pathol. 2021;30(3):1008-1022.
  16. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479-504.
  17. Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17(4):347-361.
  18. Pera MC, Romeo DM, Graziano A, et al. Sleep disorders in spinal muscular atrophy.Sleep Med. 2017;30(2):160-163.
  19. Trucco F, Pedemonte M, Fiorillo C, et al. Detection of early nocturnal hypoventilation in neuromuscular disorders. J Int Med Res. 2018;46(3):1153-1161.
  20. BertrĂ¡n K, Sans Capdevila O, Nascimiento A, et al. Sleep breathing disorders in pediatric patients with spinal muscular atrophy 2. Sleep Med. 2022;89:85-89.
  21. AlBalawi MM, Castro-Codesal M, Featherstone R, et al. Outcomes of Long-Term Noninvasive Ventilation Use in Children with Neuromuscular Disease: Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2022;19(1):109-119.
  22. Veldhoen ES, Wijngaarde CA, Hulzebos EHJ, et al. Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study. Orphanet J Rare Dis. 2022;17(1):70.
  23. Trucco F, Ridout D, Scoto M, et al. Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study. Neurology. 2021;96(4):e587-e599.
  24. American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.
  25. Won YH, Choi WA, Lee JW, et al. Sleep Transcutaneous vs. End-Tidal CO2 Monitoring for Patients with Neuromuscular Disease. Am J Phys Med Rehabil. 2016;95(2):91-95.
  26. Menard J, Seferian AM, Fleurence E, et al. Respiratory management of spinal muscular atrophy type 1 patients treated with nusinersen. Pediatr Pulmonol. 2022;Mar 20.
  27. Chacko A, Sly PD, Ware RS, et al. Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1-3. Thorax. 2022;77(1):40-46.
  28. Heitschmidt L, Pichlmaier L, Eckerland M, et al. Nusinersen does not improve lung function in a cohort of children with spinal muscular atrophy - A single-center retrospective study. Eur J Paediatr Neurol. 2021;31:88-91.
  29. Lavie M, Diamant N, Cahal M, et al. Nusinersen for spinal muscular atrophy type 1: Real-world respiratory experience. Pediatr Pulmonol. 2021;56(1):291-298.
  30. Ou SF, Ho CS, Lee WT, et al. Natural history in spinal muscular atrophy Type I in Taiwanese population: A longitudinal study. Brain Dev. 2021;43(1):127-134.
  31. Gregoretti C, Ottonello G, Chiarini Testa MB, et al. Survival of patients with spinal muscular atrophy type 1. Pediatrics. 2013;131(5):e1509-e1514.